Stay updated on Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Minor wording changes in the Publications section and a page revision label (Revision: v3.3.2) were added; these do not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:39:05.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page. This change shifts administrative content but does not modify the study details or results.
    Difference
    0.2%
    Check dated 2025-11-17T19:54:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Taiwan study sites were updated: Tainan City, Taiwan, 704 and 710 were removed and replaced with Tainan, Taiwan, 704 and 710.
    Difference
    0.0%
    Check dated 2025-11-10T17:21:01.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The Study Details page for NCT03412773 appears the same in both screenshots, with no changes to the main study information.
    Difference
    0.2%
    Check dated 2025-11-03T13:22:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added detailed trial results and substudy information for the tislelizumab vs sorafenib study (RATIONALE-301), including endpoints, locations, and Japanese safety run-in; removed reference to the 2024-01-10 results submission page in favor of the updated results-centric content.
    Difference
    100%
    Check dated 2025-10-20T07:22:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Update includes a government operations notice and new version tag v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T02:01:32.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.